Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample
Authors
Keywords
-
Journal
International Journal of Environmental Research and Public Health
Volume 19, Issue 18, Pages 11353
Publisher
MDPI AG
Online
2022-09-13
DOI
10.3390/ijerph191811353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample
- (2022) Grant Jones et al. Scientific Reports
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
- (2022) Michael P. Bogenschutz et al. JAMA Psychiatry
- Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year
- (2021) Otto Simonsson et al. HYPERTENSION
- Associations between lifetime classic psychedelic use and markers of physical health
- (2021) Otto Simonsson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychedelics and health behaviour change
- (2021) Pedro J Teixeira et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Associations between lifetime classic psychedelic use and cardiometabolic diseases
- (2021) Otto Simonsson et al. Scientific Reports
- Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers
- (2020) A Murphy-Beiner et al. PSYCHOPHARMACOLOGY
- Long-term effects of psychedelic drugs: A systematic review
- (2020) Jacob S. Aday et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The Current Status of Psychedelics in Psychiatry
- (2020) David Nutt et al. JAMA Psychiatry
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Determinants of sickness absence rate among Finnish municipal employees
- (2019) Tiina Vuorio et al. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
- Prevalence and epidemiological associates of novel psychedelic use in the United States adult population
- (2019) James D Sexton et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The relative impact of smoking, alcohol use and drug use on general sickness absence among Norwegian employees
- (2019) Ingeborg Lund et al. BMC PUBLIC HEALTH
- Cessation and reduction in alcohol consumption and misuse after psychedelic use
- (2019) Albert Garcia-Romeu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging
- (2019) Christopher B. Germann MEDICAL HYPOTHESES
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- (2018) Matthew W. Johnson et al. NEUROPHARMACOLOGY
- Explaining the gender gap in sickness absence
- (2018) K A Østby et al. OCCUPATIONAL MEDICINE-OXFORD
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
- (2018) Rafael G. dos Santos et al. Expert Review of Clinical Pharmacology
- The relationships of classic psychedelic use with criminal behavior in the United States adult population
- (2017) Peter S Hendricks et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The association of psychedelic use and opioid use disorders among illicit users in the United States
- (2017) Vincent D Pisano et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
- (2017) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Mental Health and Cardiovascular Disease
- (2016) Ashish Chaddha et al. AMERICAN JOURNAL OF MEDICINE
- The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization
- (2016) Ede Frecska et al. Frontiers in Pharmacology
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Gender difference in sickness absence from work: a multiple mediation analysis of psychosocial factors
- (2013) Annalisa Casini et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Psychedelics and Mental Health: A Population Study
- (2013) Teri S. Krebs et al. PLoS One
- Work productivity and health of informal caregivers of persons with advanced cancer
- (2011) Susan R. Mazanec et al. RESEARCH IN NURSING & HEALTH
- Drug harms in the UK: a multicriteria decision analysis
- (2010) David J Nutt et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now